NantHealth Inc (NYSE:NH) had its price objective cut by Jefferies Group LLC from $5.50 to $5.00 in a research report report published on Wednesday morning. They currently have a buy rating on the stock. Jefferies Group also issued estimates for NantHealth’s Q3 2017 earnings at ($0.24) EPS, Q4 2017 earnings at ($0.28) EPS, FY2017 earnings at ($1.44) EPS, Q1 2018 earnings at ($0.21) EPS, Q2 2018 earnings at ($0.20) EPS, Q3 2018 earnings at ($0.19) EPS and FY2018 earnings at ($0.78) EPS.

Separately, Canaccord Genuity restated a buy rating and issued a $6.00 price objective (down previously from $8.00) on shares of NantHealth in a research report on Monday, August 21st. Five analysts have rated the stock with a buy rating, NantHealth has a consensus rating of Buy and an average price target of $8.55.

NantHealth (NH) traded down 4.04% on Wednesday, hitting $2.85. The stock had a trading volume of 166,880 shares. NantHealth has a 12-month low of $2.84 and a 12-month high of $15.80. The company’s market cap is $347.55 million. The company’s 50 day moving average price is $3.88 and its 200-day moving average price is $4.43.

NantHealth (NYSE:NH) last posted its earnings results on Thursday, August 10th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.26) by $0.32. NantHealth had a negative net margin of 267.11% and a negative return on equity of 83.97%. The firm had revenue of $26.23 million during the quarter, compared to the consensus estimate of $31.28 million. During the same quarter last year, the firm posted ($0.15) EPS. The business’s revenue was down 16.7% on a year-over-year basis. Equities research analysts anticipate that NantHealth will post ($0.70) EPS for the current year.

WARNING: “NantHealth Inc (NH) Given New $5.00 Price Target at Jefferies Group LLC” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another domain, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this article can be read at https://www.thecerbatgem.com/2017/08/27/nanthealth-inc-nh-given-new-5-00-price-target-at-jefferies-group-llc.html.

A number of hedge funds and other institutional investors have recently bought and sold shares of NH. TIAA CREF Investment Management LLC boosted its position in NantHealth by 68.6% in the first quarter. TIAA CREF Investment Management LLC now owns 20,200 shares of the company’s stock valued at $100,000 after buying an additional 8,217 shares during the period. Alliancebernstein L.P. bought a new position in NantHealth during the second quarter valued at $102,000. Bank of America Corp DE boosted its position in NantHealth by 366.4% in the first quarter. Bank of America Corp DE now owns 25,069 shares of the company’s stock valued at $125,000 after buying an additional 19,694 shares during the period. GSA Capital Partners LLP bought a new position in NantHealth during the second quarter valued at $121,000. Finally, Teachers Advisors LLC boosted its position in NantHealth by 351.8% in the second quarter. Teachers Advisors LLC now owns 31,578 shares of the company’s stock valued at $134,000 after buying an additional 24,588 shares during the period.

NantHealth Company Profile

NantHealth, Inc is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples.

Receive News & Stock Ratings for NantHealth Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth Inc and related stocks with our FREE daily email newsletter.